Form 4: Rani Therapeutics Holdings Executive Reports Stock Transacti
Insider Transaction (Form 4)
Alireza Javadi, Chief Technical Officer of Rani Therapeutics Holdings, Inc., reported a transaction in 309 shares of common stock on September 27, 2026.
Summary
- Tax/exercise-price withholding: disposed of 309 Class A Common Stock at $0.76 ($235) on September 27, 2026; holds 9,071 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Alireza Javadi — Officer (Chief Technical Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-27 | Tax/exercise-price withholding | Class A Common Stock | 309 | $1 | $235 | 9,071 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-27 | Tax/exercise-price withholding (309 shares) |
Keywords
insider transaction, Form 4, RANI, Rani Therapeutics Holdings, Inc., neutral, Alireza Javadi
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.